Abercrombie George B Form 3 Brickell Biotech / GEORGE B ABERCROMBIE ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

ABERCROMBIE GEORGE B

(Last) (First) (Middle)

C/O BRICKELL BIOTECH, INC.

5777 CENTRAL AVENUE, SUITE 102

(Street)

BOULDER CO 80301

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/31/2019

3. Issuer Name and Ticker or Trading Symbol
Brickell Biotech, Inc. [ BBI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,230	D
Common Stock	12,082	I	By Spouse as Trustee
Common Stock	12,082	I	By Spouse as Trustee

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	01/25/2011	01/25/2021	Common Stock	8,630	2.9	D
Stock Options	02/14/2014	02/14/2024	Common Stock	2,589	6.37	D
Stock Options	04/22/2015	04/22/2025	Common Stock	8,630	12.17	D
Stock Options	12/15/2016	12/15/2026	Common Stock	3,452	12.17	D
Stock Options	12/15/2019	12/15/2028	Common Stock	5,178	16.45	D
Stock Options	08/30/2020	08/30/2029	Common Stock	34,521	4.76	D
Warrants	08/30/2019	08/30/2019	Common Stock	3,316	10.36	D

Explanation of Responses:

Remarks:

	/s/ George B. Abercrombie	09/09/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.